Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1991
|
| gptkbp:ATCCode |
L01BB05
|
| gptkbp:brand |
gptkb:fludarabine
|
| gptkbp:CASNumber |
75607-67-9
|
| gptkbp:chemicalFormula |
C10H12FN5O4
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fludara
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:mechanismOfAction |
purine analog
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
fever
nausea vomiting infections myelosuppression |
| gptkbp:synonym |
gptkb:fludarabine_phosphate
|
| gptkbp:usedFor |
chronic lymphocytic leukemia
|
| gptkbp:bfsParent |
gptkb:fludarabine
|
| gptkbp:bfsLayer |
7
|